Acquisition of a "NovaSeq 6000"

Section I: Contracting authority/entity

I.1) Name and addresses

University of Copenhagen
Nørregade 10
Copenhagen
1017
Denmark
Contact person: Jens Hoejer Larsen
E-mail: jens.hoejer.larsen@adm.ku.dk
NUTS code: DK011

Internet address(es):

Main address: www.oko-okonomi@adm.ku.dk

I.4) Type of the contracting authority

Body governed by public law

I.5) Main activity

Education

Section II: Object

II.1) Scope of the procurement

II.1.1) Title:

Acquisition of a "NovaSeq 6000"

Reference number: 510-001318-3860

II.1.2) Main CPV code

38000000

II.1.3) Type of contract

Supplies

II.1.4) Short description:

The Novo Nordisk Foundation Center for Basic Metabolic Research intends to acquire a sequencer to be used for research within metabolism. The sequencer is required to be flexible with a scalable output from low output ~70 GB for new test protocols to high output ~6 000 GB for implemented protocols.

II.1.6) Information about lots

This contract is divided into lots: no

II.1.7) Total value of the procurement (excluding VAT)

Value excluding VAT: 6 500 000.00 DKK

II.2) Description

II.2.1) Title:

II.2.2) Additional CPV code(s)

II.2.3) Place of performance

NUTS code: DK011

II.2.4) Description of the procurement:

The Novo Nordisk Foundation Center for Basic Metabolic Research intends to acquire a sequencer to be used for research within metabolism. The sequencer is required to be flexible with a scalable output from low output ~70 GB for new test protocols to high output ~6 000 GB for implemented protocols. For high output assays it is further necessary that samples can be loaded in parallel to avoid mixing of specific samples. It is required that the sequencer is compatible with the centers current sequencer (NextSeq) that will be used as backup. It is essential that the sequencer is compatible with the chemistry used in our implemented protocols (Sequencing by Synthesis).

The contracting institution is the Novo Nordisk Foundation (NNF) Center for Basic Metabolic Research (CBMR). It was established on 1.10.2010, funded by a generous ( 885 000 000 DKK), unrestricted grant from the Foundation. The Center is fully integrated within the Faculty of Health and Medical Sciences at the University of Copenhagen with direct reference to the Dean. Our mission is to discover fundamental processes that underpin the development of transformative diagnostics and prevention/treatment strategies for metabolic diseases.

II.2.5) Award criteria

II.2.11) Information about options

Options: no

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: no

II.2.14) Additional information

Section IV: Procedure

IV.1) Description

IV.1.1) Type of procedure

Negotiated procedure without prior publication

The works, supplies or services can be provided only by a particular economic operator for the following reason:
- absence of competition for technical reasons

Explanation:

The sequencer is required to be flexible with a scalable output from low output ~70 GB for new test protocols to high output ~6 000 GB for implemented protocols. For high output assays it is further necessary that samples can be loaded in parallel to avoid mixing of specific samples. It is required that the sequencer is compatible with the centers current sequencer (NextSeq), that will be used as backup. It is essential that the sequencer is compatible with the chemistry used in our implemented protocols (Sequencing by Synthesis).

The NovaSeq 6 000 System uses Illumina sequencing by synthesis chemistry with patented reversible terminator chemistry.

Only one supplier has a product in concordance with these requirements, therefore the Novo Nordisk Foundation Center for Basic Metabolic Research has decided to acquire a NovaSeq 6 000 from the company Illumina.

IV.1.3) Information about framework agreement

IV.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: yes

IV.2) Administrative information

IV.2.1) Previous publication concerning this procedure

Section V: Award of contract/concession

V.2) Award of contract/concession

V.2.1) Date of contract award decision:

16/08/2018

V.2.2) Information about tenders

The contract has been awarded to a group of economic operators: no

V.2.3) Name and address of the contractor/concessionaire

Illumina Denmark ApS
34087423
Ørestads Boulevard 73
Copenhagen
2300 København S
Denmark
Telephone: +45 30218330
E-mail: jnielsen@illumina.com
NUTS code: DK011

Internet address: https://emea.illumina.com/

The contractor/concessionaire will be an SME: yes

V.2.4) Information on value of the contract/lot/concession (excluding VAT)

Total value of the contract/lot/concession: 6 500 000.00 DKK

V.2.5) Information about subcontracting

Section VI: Complementary information

VI.3) Additional information:

VI.4) Procedures for review

VI.4.1) Review body

Danish Public Contracts Appeals Board
Nævnenes Hus, Toldboden 2
Viborg
8800
Denmark
Telephone: +45 72405600
E-mail: klfu@naevneneshus.dk

Internet address: https://erhvervsstyrelsen.dk/klagenaevnet-for-udbud

VI.4.2) Body responsible for mediation procedures

VI.4.3) Review procedure

VI.4.4) Service from which information about the review procedure may be obtained

VI.5) Date of dispatch of this notice:

22/08/2018

Fakta om udbudet

Vindere

Acquisition of a "NovaSeq 6000"

University of Copenhagen